Global Artificial Intelligence in Epidemiology Supply, Demand and Key Producers, 2024-2030

Global Artificial Intelligence in Epidemiology Supply, Demand and Key Producers, 2024-2030

Page: 167

Published Date: 03 Mar 2024

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Artificial Intelligence in Epidemiology market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

China and the United States are two leaders in AI industry. On the AI 100 list (2022) released by CB Insights, the number of companies in the United States ranks first, with more than 70 companies, followed by the United Kingdom, with 8 companies on the list. China and Canada both holds 5 companies on the list. According to data from the China Academy of Information and Communications Technology, the scale of China's core artificial intelligence industry reached ¥508 billion in 2022, a year-on-year increase of 18%. From 2013 to November 2022, the cumulative number of patent applications for artificial intelligence inventions in the world reached 729,000, and the cumulative number of applications in China reached 389,000, accounting for 53.4%. However, the Global Artificial Intelligence Innovation Index Report 2021 released by the China Institute of Scientific and Technological Information shows that the overall strength of the United States is still far ahead. The number of artificial intelligence companies in the United States is about 4,670, while China has only 880. China's data center is less than 1/120 of that of the United States.

This report studies the global Artificial Intelligence in Epidemiology demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Artificial Intelligence in Epidemiology, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Artificial Intelligence in Epidemiology that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Artificial Intelligence in Epidemiology total market, 2019-2030, (USD Million)
Global Artificial Intelligence in Epidemiology total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Artificial Intelligence in Epidemiology total market, key domestic companies and share, (USD Million)
Global Artificial Intelligence in Epidemiology revenue by player and market share 2019-2024, (USD Million)
Global Artificial Intelligence in Epidemiology total market by Type, CAGR, 2019-2030, (USD Million)
Global Artificial Intelligence in Epidemiology total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Artificial Intelligence in Epidemiology market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Informatics, AdvancedMD, Agilent Technologies, Allscripts Healthcare, Athenahealth, Autoscribe Informatics, Cerner Corporation, Change Healthcare and Cognizant, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Artificial Intelligence in Epidemiology market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Artificial Intelligence in Epidemiology Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Artificial Intelligence in Epidemiology Market, Segmentation by Type
Hardware Technology
Software Technology

Global Artificial Intelligence in Epidemiology Market, Segmentation by Application
Disease and Syndromic Surveillance
Infection Prediction and Forecasting
Immunization Information Systems
Public Sentiment Analysis
Environmental Impact Analysis
Drug Discovery, Safety, and Risk Analysis
Monitoring Population and Incidence
Knowledge Representation and Mass Notification

Companies Profiled:
Abbott Informatics
AdvancedMD
Agilent Technologies
Allscripts Healthcare
Athenahealth
Autoscribe Informatics
Cerner Corporation
Change Healthcare
Cognizant
CPSI
CureMD Healthcare
eClinicalWorks
e-Mds Inc.
Epic Systems
GE Healthcare
Google
Graphcore
Greenway Health
IBM
Intel
InterSystems
Kareo
Medhost
Meditech
Medtronic
Micron Technology
Microsoft
NextGen Healthcare
Nvidia
Optum Inc.

Key Questions Answered
1. How big is the global Artificial Intelligence in Epidemiology market?
2. What is the demand of the global Artificial Intelligence in Epidemiology market?
3. What is the year over year growth of the global Artificial Intelligence in Epidemiology market?
4. What is the total value of the global Artificial Intelligence in Epidemiology market?
5. Who are the major players in the global Artificial Intelligence in Epidemiology market?
btl

Table of Contents

1 Supply Summary
1.1 Artificial Intelligence in Epidemiology Introduction
1.2 World Artificial Intelligence in Epidemiology Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Artificial Intelligence in Epidemiology Total Market by Region (by Headquarter Location)
1.3.1 World Artificial Intelligence in Epidemiology Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Artificial Intelligence in Epidemiology Market Size (2019-2030)
1.3.3 China Artificial Intelligence in Epidemiology Market Size (2019-2030)
1.3.4 Europe Artificial Intelligence in Epidemiology Market Size (2019-2030)
1.3.5 Japan Artificial Intelligence in Epidemiology Market Size (2019-2030)
1.3.6 South Korea Artificial Intelligence in Epidemiology Market Size (2019-2030)
1.3.7 ASEAN Artificial Intelligence in Epidemiology Market Size (2019-2030)
1.3.8 India Artificial Intelligence in Epidemiology Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Artificial Intelligence in Epidemiology Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Artificial Intelligence in Epidemiology Major Market Trends

2 Demand Summary
2.1 World Artificial Intelligence in Epidemiology Consumption Value (2019-2030)
2.2 World Artificial Intelligence in Epidemiology Consumption Value by Region
2.2.1 World Artificial Intelligence in Epidemiology Consumption Value by Region (2019-2024)
2.2.2 World Artificial Intelligence in Epidemiology Consumption Value Forecast by Region (2025-2030)
2.3 United States Artificial Intelligence in Epidemiology Consumption Value (2019-2030)
2.4 China Artificial Intelligence in Epidemiology Consumption Value (2019-2030)
2.5 Europe Artificial Intelligence in Epidemiology Consumption Value (2019-2030)
2.6 Japan Artificial Intelligence in Epidemiology Consumption Value (2019-2030)
2.7 South Korea Artificial Intelligence in Epidemiology Consumption Value (2019-2030)
2.8 ASEAN Artificial Intelligence in Epidemiology Consumption Value (2019-2030)
2.9 India Artificial Intelligence in Epidemiology Consumption Value (2019-2030)

3 World Artificial Intelligence in Epidemiology Companies Competitive Analysis
3.1 World Artificial Intelligence in Epidemiology Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Artificial Intelligence in Epidemiology Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Artificial Intelligence in Epidemiology in 2023
3.2.3 Global Concentration Ratios (CR8) for Artificial Intelligence in Epidemiology in 2023
3.3 Artificial Intelligence in Epidemiology Company Evaluation Quadrant
3.4 Artificial Intelligence in Epidemiology Market: Overall Company Footprint Analysis
3.4.1 Artificial Intelligence in Epidemiology Market: Region Footprint
3.4.2 Artificial Intelligence in Epidemiology Market: Company Product Type Footprint
3.4.3 Artificial Intelligence in Epidemiology Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: Artificial Intelligence in Epidemiology Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Artificial Intelligence in Epidemiology Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Artificial Intelligence in Epidemiology Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Artificial Intelligence in Epidemiology Consumption Value Comparison
4.2.1 United States VS China: Artificial Intelligence in Epidemiology Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Artificial Intelligence in Epidemiology Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Artificial Intelligence in Epidemiology Companies and Market Share, 2019-2024
4.3.1 United States Based Artificial Intelligence in Epidemiology Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Artificial Intelligence in Epidemiology Revenue, (2019-2024)
4.4 China Based Companies Artificial Intelligence in Epidemiology Revenue and Market Share, 2019-2024
4.4.1 China Based Artificial Intelligence in Epidemiology Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Artificial Intelligence in Epidemiology Revenue, (2019-2024)
4.5 Rest of World Based Artificial Intelligence in Epidemiology Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Artificial Intelligence in Epidemiology Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Artificial Intelligence in Epidemiology Revenue, (2019-2024)

5 Market Analysis by Type
5.1 World Artificial Intelligence in Epidemiology Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Hardware Technology
5.2.2 Software Technology
5.3 Market Segment by Type
5.3.1 World Artificial Intelligence in Epidemiology Market Size by Type (2019-2024)
5.3.2 World Artificial Intelligence in Epidemiology Market Size by Type (2025-2030)
5.3.3 World Artificial Intelligence in Epidemiology Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
6.1 World Artificial Intelligence in Epidemiology Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Disease and Syndromic Surveillance
6.2.2 Infection Prediction and Forecasting
6.2.3 Immunization Information Systems
6.2.4 Public Sentiment Analysis
6.2.5 Public Sentiment Analysis
6.2.6 Drug Discovery, Safety, and Risk Analysis
6.2.7 Monitoring Population and Incidence
6.2.8 Knowledge Representation and Mass Notification
6.3 Market Segment by Application
6.3.1 World Artificial Intelligence in Epidemiology Market Size by Application (2019-2024)
6.3.2 World Artificial Intelligence in Epidemiology Market Size by Application (2025-2030)
6.3.3 World Artificial Intelligence in Epidemiology Market Size by Application (2019-2030)

7 Company Profiles
7.1 Abbott Informatics
7.1.1 Abbott Informatics Details
7.1.2 Abbott Informatics Major Business
7.1.3 Abbott Informatics Artificial Intelligence in Epidemiology Product and Services
7.1.4 Abbott Informatics Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Abbott Informatics Recent Developments/Updates
7.1.6 Abbott Informatics Competitive Strengths & Weaknesses
7.2 AdvancedMD
7.2.1 AdvancedMD Details
7.2.2 AdvancedMD Major Business
7.2.3 AdvancedMD Artificial Intelligence in Epidemiology Product and Services
7.2.4 AdvancedMD Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 AdvancedMD Recent Developments/Updates
7.2.6 AdvancedMD Competitive Strengths & Weaknesses
7.3 Agilent Technologies
7.3.1 Agilent Technologies Details
7.3.2 Agilent Technologies Major Business
7.3.3 Agilent Technologies Artificial Intelligence in Epidemiology Product and Services
7.3.4 Agilent Technologies Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Agilent Technologies Recent Developments/Updates
7.3.6 Agilent Technologies Competitive Strengths & Weaknesses
7.4 Allscripts Healthcare
7.4.1 Allscripts Healthcare Details
7.4.2 Allscripts Healthcare Major Business
7.4.3 Allscripts Healthcare Artificial Intelligence in Epidemiology Product and Services
7.4.4 Allscripts Healthcare Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Allscripts Healthcare Recent Developments/Updates
7.4.6 Allscripts Healthcare Competitive Strengths & Weaknesses
7.5 Athenahealth
7.5.1 Athenahealth Details
7.5.2 Athenahealth Major Business
7.5.3 Athenahealth Artificial Intelligence in Epidemiology Product and Services
7.5.4 Athenahealth Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Athenahealth Recent Developments/Updates
7.5.6 Athenahealth Competitive Strengths & Weaknesses
7.6 Autoscribe Informatics
7.6.1 Autoscribe Informatics Details
7.6.2 Autoscribe Informatics Major Business
7.6.3 Autoscribe Informatics Artificial Intelligence in Epidemiology Product and Services
7.6.4 Autoscribe Informatics Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Autoscribe Informatics Recent Developments/Updates
7.6.6 Autoscribe Informatics Competitive Strengths & Weaknesses
7.7 Cerner Corporation
7.7.1 Cerner Corporation Details
7.7.2 Cerner Corporation Major Business
7.7.3 Cerner Corporation Artificial Intelligence in Epidemiology Product and Services
7.7.4 Cerner Corporation Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Cerner Corporation Recent Developments/Updates
7.7.6 Cerner Corporation Competitive Strengths & Weaknesses
7.8 Change Healthcare
7.8.1 Change Healthcare Details
7.8.2 Change Healthcare Major Business
7.8.3 Change Healthcare Artificial Intelligence in Epidemiology Product and Services
7.8.4 Change Healthcare Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Change Healthcare Recent Developments/Updates
7.8.6 Change Healthcare Competitive Strengths & Weaknesses
7.9 Cognizant
7.9.1 Cognizant Details
7.9.2 Cognizant Major Business
7.9.3 Cognizant Artificial Intelligence in Epidemiology Product and Services
7.9.4 Cognizant Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Cognizant Recent Developments/Updates
7.9.6 Cognizant Competitive Strengths & Weaknesses
7.10 CPSI
7.10.1 CPSI Details
7.10.2 CPSI Major Business
7.10.3 CPSI Artificial Intelligence in Epidemiology Product and Services
7.10.4 CPSI Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 CPSI Recent Developments/Updates
7.10.6 CPSI Competitive Strengths & Weaknesses
7.11 CureMD Healthcare
7.11.1 CureMD Healthcare Details
7.11.2 CureMD Healthcare Major Business
7.11.3 CureMD Healthcare Artificial Intelligence in Epidemiology Product and Services
7.11.4 CureMD Healthcare Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 CureMD Healthcare Recent Developments/Updates
7.11.6 CureMD Healthcare Competitive Strengths & Weaknesses
7.12 eClinicalWorks
7.12.1 eClinicalWorks Details
7.12.2 eClinicalWorks Major Business
7.12.3 eClinicalWorks Artificial Intelligence in Epidemiology Product and Services
7.12.4 eClinicalWorks Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 eClinicalWorks Recent Developments/Updates
7.12.6 eClinicalWorks Competitive Strengths & Weaknesses
7.13 e-Mds Inc.
7.13.1 e-Mds Inc. Details
7.13.2 e-Mds Inc. Major Business
7.13.3 e-Mds Inc. Artificial Intelligence in Epidemiology Product and Services
7.13.4 e-Mds Inc. Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 e-Mds Inc. Recent Developments/Updates
7.13.6 e-Mds Inc. Competitive Strengths & Weaknesses
7.14 Epic Systems
7.14.1 Epic Systems Details
7.14.2 Epic Systems Major Business
7.14.3 Epic Systems Artificial Intelligence in Epidemiology Product and Services
7.14.4 Epic Systems Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.14.5 Epic Systems Recent Developments/Updates
7.14.6 Epic Systems Competitive Strengths & Weaknesses
7.15 GE Healthcare
7.15.1 GE Healthcare Details
7.15.2 GE Healthcare Major Business
7.15.3 GE Healthcare Artificial Intelligence in Epidemiology Product and Services
7.15.4 GE Healthcare Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.15.5 GE Healthcare Recent Developments/Updates
7.15.6 GE Healthcare Competitive Strengths & Weaknesses
7.16 Google
7.16.1 Google Details
7.16.2 Google Major Business
7.16.3 Google Artificial Intelligence in Epidemiology Product and Services
7.16.4 Google Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.16.5 Google Recent Developments/Updates
7.16.6 Google Competitive Strengths & Weaknesses
7.17 Graphcore
7.17.1 Graphcore Details
7.17.2 Graphcore Major Business
7.17.3 Graphcore Artificial Intelligence in Epidemiology Product and Services
7.17.4 Graphcore Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.17.5 Graphcore Recent Developments/Updates
7.17.6 Graphcore Competitive Strengths & Weaknesses
7.18 Greenway Health
7.18.1 Greenway Health Details
7.18.2 Greenway Health Major Business
7.18.3 Greenway Health Artificial Intelligence in Epidemiology Product and Services
7.18.4 Greenway Health Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.18.5 Greenway Health Recent Developments/Updates
7.18.6 Greenway Health Competitive Strengths & Weaknesses
7.19 IBM
7.19.1 IBM Details
7.19.2 IBM Major Business
7.19.3 IBM Artificial Intelligence in Epidemiology Product and Services
7.19.4 IBM Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.19.5 IBM Recent Developments/Updates
7.19.6 IBM Competitive Strengths & Weaknesses
7.20 Intel
7.20.1 Intel Details
7.20.2 Intel Major Business
7.20.3 Intel Artificial Intelligence in Epidemiology Product and Services
7.20.4 Intel Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.20.5 Intel Recent Developments/Updates
7.20.6 Intel Competitive Strengths & Weaknesses
7.21 InterSystems
7.21.1 InterSystems Details
7.21.2 InterSystems Major Business
7.21.3 InterSystems Artificial Intelligence in Epidemiology Product and Services
7.21.4 InterSystems Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.21.5 InterSystems Recent Developments/Updates
7.21.6 InterSystems Competitive Strengths & Weaknesses
7.22 Kareo
7.22.1 Kareo Details
7.22.2 Kareo Major Business
7.22.3 Kareo Artificial Intelligence in Epidemiology Product and Services
7.22.4 Kareo Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.22.5 Kareo Recent Developments/Updates
7.22.6 Kareo Competitive Strengths & Weaknesses
7.23 Medhost
7.23.1 Medhost Details
7.23.2 Medhost Major Business
7.23.3 Medhost Artificial Intelligence in Epidemiology Product and Services
7.23.4 Medhost Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.23.5 Medhost Recent Developments/Updates
7.23.6 Medhost Competitive Strengths & Weaknesses
7.24 Meditech
7.24.1 Meditech Details
7.24.2 Meditech Major Business
7.24.3 Meditech Artificial Intelligence in Epidemiology Product and Services
7.24.4 Meditech Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.24.5 Meditech Recent Developments/Updates
7.24.6 Meditech Competitive Strengths & Weaknesses
7.25 Medtronic
7.25.1 Medtronic Details
7.25.2 Medtronic Major Business
7.25.3 Medtronic Artificial Intelligence in Epidemiology Product and Services
7.25.4 Medtronic Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.25.5 Medtronic Recent Developments/Updates
7.25.6 Medtronic Competitive Strengths & Weaknesses
7.26 Micron Technology
7.26.1 Micron Technology Details
7.26.2 Micron Technology Major Business
7.26.3 Micron Technology Artificial Intelligence in Epidemiology Product and Services
7.26.4 Micron Technology Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.26.5 Micron Technology Recent Developments/Updates
7.26.6 Micron Technology Competitive Strengths & Weaknesses
7.27 Microsoft
7.27.1 Microsoft Details
7.27.2 Microsoft Major Business
7.27.3 Microsoft Artificial Intelligence in Epidemiology Product and Services
7.27.4 Microsoft Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.27.5 Microsoft Recent Developments/Updates
7.27.6 Microsoft Competitive Strengths & Weaknesses
7.28 NextGen Healthcare
7.28.1 NextGen Healthcare Details
7.28.2 NextGen Healthcare Major Business
7.28.3 NextGen Healthcare Artificial Intelligence in Epidemiology Product and Services
7.28.4 NextGen Healthcare Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.28.5 NextGen Healthcare Recent Developments/Updates
7.28.6 NextGen Healthcare Competitive Strengths & Weaknesses
7.29 Nvidia
7.29.1 Nvidia Details
7.29.2 Nvidia Major Business
7.29.3 Nvidia Artificial Intelligence in Epidemiology Product and Services
7.29.4 Nvidia Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.29.5 Nvidia Recent Developments/Updates
7.29.6 Nvidia Competitive Strengths & Weaknesses
7.30 Optum Inc.
7.30.1 Optum Inc. Details
7.30.2 Optum Inc. Major Business
7.30.3 Optum Inc. Artificial Intelligence in Epidemiology Product and Services
7.30.4 Optum Inc. Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.30.5 Optum Inc. Recent Developments/Updates
7.30.6 Optum Inc. Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Artificial Intelligence in Epidemiology Industry Chain
8.2 Artificial Intelligence in Epidemiology Upstream Analysis
8.3 Artificial Intelligence in Epidemiology Midstream Analysis
8.4 Artificial Intelligence in Epidemiology Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Artificial Intelligence in Epidemiology Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Artificial Intelligence in Epidemiology Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Artificial Intelligence in Epidemiology Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Artificial Intelligence in Epidemiology Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Artificial Intelligence in Epidemiology Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Artificial Intelligence in Epidemiology Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Artificial Intelligence in Epidemiology Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Artificial Intelligence in Epidemiology Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Artificial Intelligence in Epidemiology Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Artificial Intelligence in Epidemiology Players in 2023
Table 12. World Artificial Intelligence in Epidemiology Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Artificial Intelligence in Epidemiology Company Evaluation Quadrant
Table 14. Head Office of Key Artificial Intelligence in Epidemiology Player
Table 15. Artificial Intelligence in Epidemiology Market: Company Product Type Footprint
Table 16. Artificial Intelligence in Epidemiology Market: Company Product Application Footprint
Table 17. Artificial Intelligence in Epidemiology Mergers & Acquisitions Activity
Table 18. United States VS China Artificial Intelligence in Epidemiology Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Artificial Intelligence in Epidemiology Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Artificial Intelligence in Epidemiology Companies, Headquarters (States, Country)
Table 21. United States Based Companies Artificial Intelligence in Epidemiology Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Artificial Intelligence in Epidemiology Revenue Market Share (2019-2024)
Table 23. China Based Artificial Intelligence in Epidemiology Companies, Headquarters (Province, Country)
Table 24. China Based Companies Artificial Intelligence in Epidemiology Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Artificial Intelligence in Epidemiology Revenue Market Share (2019-2024)
Table 26. Rest of World Based Artificial Intelligence in Epidemiology Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Artificial Intelligence in Epidemiology Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Artificial Intelligence in Epidemiology Revenue Market Share (2019-2024)
Table 29. World Artificial Intelligence in Epidemiology Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Artificial Intelligence in Epidemiology Market Size by Type (2019-2024) & (USD Million)
Table 31. World Artificial Intelligence in Epidemiology Market Size by Type (2025-2030) & (USD Million)
Table 32. World Artificial Intelligence in Epidemiology Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Artificial Intelligence in Epidemiology Market Size by Application (2019-2024) & (USD Million)
Table 34. World Artificial Intelligence in Epidemiology Market Size by Application (2025-2030) & (USD Million)
Table 35. Abbott Informatics Basic Information, Area Served and Competitors
Table 36. Abbott Informatics Major Business
Table 37. Abbott Informatics Artificial Intelligence in Epidemiology Product and Services
Table 38. Abbott Informatics Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Abbott Informatics Recent Developments/Updates
Table 40. Abbott Informatics Competitive Strengths & Weaknesses
Table 41. AdvancedMD Basic Information, Area Served and Competitors
Table 42. AdvancedMD Major Business
Table 43. AdvancedMD Artificial Intelligence in Epidemiology Product and Services
Table 44. AdvancedMD Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. AdvancedMD Recent Developments/Updates
Table 46. AdvancedMD Competitive Strengths & Weaknesses
Table 47. Agilent Technologies Basic Information, Area Served and Competitors
Table 48. Agilent Technologies Major Business
Table 49. Agilent Technologies Artificial Intelligence in Epidemiology Product and Services
Table 50. Agilent Technologies Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Agilent Technologies Recent Developments/Updates
Table 52. Agilent Technologies Competitive Strengths & Weaknesses
Table 53. Allscripts Healthcare Basic Information, Area Served and Competitors
Table 54. Allscripts Healthcare Major Business
Table 55. Allscripts Healthcare Artificial Intelligence in Epidemiology Product and Services
Table 56. Allscripts Healthcare Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Allscripts Healthcare Recent Developments/Updates
Table 58. Allscripts Healthcare Competitive Strengths & Weaknesses
Table 59. Athenahealth Basic Information, Area Served and Competitors
Table 60. Athenahealth Major Business
Table 61. Athenahealth Artificial Intelligence in Epidemiology Product and Services
Table 62. Athenahealth Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Athenahealth Recent Developments/Updates
Table 64. Athenahealth Competitive Strengths & Weaknesses
Table 65. Autoscribe Informatics Basic Information, Area Served and Competitors
Table 66. Autoscribe Informatics Major Business
Table 67. Autoscribe Informatics Artificial Intelligence in Epidemiology Product and Services
Table 68. Autoscribe Informatics Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Autoscribe Informatics Recent Developments/Updates
Table 70. Autoscribe Informatics Competitive Strengths & Weaknesses
Table 71. Cerner Corporation Basic Information, Area Served and Competitors
Table 72. Cerner Corporation Major Business
Table 73. Cerner Corporation Artificial Intelligence in Epidemiology Product and Services
Table 74. Cerner Corporation Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Cerner Corporation Recent Developments/Updates
Table 76. Cerner Corporation Competitive Strengths & Weaknesses
Table 77. Change Healthcare Basic Information, Area Served and Competitors
Table 78. Change Healthcare Major Business
Table 79. Change Healthcare Artificial Intelligence in Epidemiology Product and Services
Table 80. Change Healthcare Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Change Healthcare Recent Developments/Updates
Table 82. Change Healthcare Competitive Strengths & Weaknesses
Table 83. Cognizant Basic Information, Area Served and Competitors
Table 84. Cognizant Major Business
Table 85. Cognizant Artificial Intelligence in Epidemiology Product and Services
Table 86. Cognizant Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Cognizant Recent Developments/Updates
Table 88. Cognizant Competitive Strengths & Weaknesses
Table 89. CPSI Basic Information, Area Served and Competitors
Table 90. CPSI Major Business
Table 91. CPSI Artificial Intelligence in Epidemiology Product and Services
Table 92. CPSI Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. CPSI Recent Developments/Updates
Table 94. CPSI Competitive Strengths & Weaknesses
Table 95. CureMD Healthcare Basic Information, Area Served and Competitors
Table 96. CureMD Healthcare Major Business
Table 97. CureMD Healthcare Artificial Intelligence in Epidemiology Product and Services
Table 98. CureMD Healthcare Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. CureMD Healthcare Recent Developments/Updates
Table 100. CureMD Healthcare Competitive Strengths & Weaknesses
Table 101. eClinicalWorks Basic Information, Area Served and Competitors
Table 102. eClinicalWorks Major Business
Table 103. eClinicalWorks Artificial Intelligence in Epidemiology Product and Services
Table 104. eClinicalWorks Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. eClinicalWorks Recent Developments/Updates
Table 106. eClinicalWorks Competitive Strengths & Weaknesses
Table 107. e-Mds Inc. Basic Information, Area Served and Competitors
Table 108. e-Mds Inc. Major Business
Table 109. e-Mds Inc. Artificial Intelligence in Epidemiology Product and Services
Table 110. e-Mds Inc. Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. e-Mds Inc. Recent Developments/Updates
Table 112. e-Mds Inc. Competitive Strengths & Weaknesses
Table 113. Epic Systems Basic Information, Area Served and Competitors
Table 114. Epic Systems Major Business
Table 115. Epic Systems Artificial Intelligence in Epidemiology Product and Services
Table 116. Epic Systems Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 117. Epic Systems Recent Developments/Updates
Table 118. Epic Systems Competitive Strengths & Weaknesses
Table 119. GE Healthcare Basic Information, Area Served and Competitors
Table 120. GE Healthcare Major Business
Table 121. GE Healthcare Artificial Intelligence in Epidemiology Product and Services
Table 122. GE Healthcare Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 123. GE Healthcare Recent Developments/Updates
Table 124. GE Healthcare Competitive Strengths & Weaknesses
Table 125. Google Basic Information, Area Served and Competitors
Table 126. Google Major Business
Table 127. Google Artificial Intelligence in Epidemiology Product and Services
Table 128. Google Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 129. Google Recent Developments/Updates
Table 130. Google Competitive Strengths & Weaknesses
Table 131. Graphcore Basic Information, Area Served and Competitors
Table 132. Graphcore Major Business
Table 133. Graphcore Artificial Intelligence in Epidemiology Product and Services
Table 134. Graphcore Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 135. Graphcore Recent Developments/Updates
Table 136. Graphcore Competitive Strengths & Weaknesses
Table 137. Greenway Health Basic Information, Area Served and Competitors
Table 138. Greenway Health Major Business
Table 139. Greenway Health Artificial Intelligence in Epidemiology Product and Services
Table 140. Greenway Health Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 141. Greenway Health Recent Developments/Updates
Table 142. Greenway Health Competitive Strengths & Weaknesses
Table 143. IBM Basic Information, Area Served and Competitors
Table 144. IBM Major Business
Table 145. IBM Artificial Intelligence in Epidemiology Product and Services
Table 146. IBM Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 147. IBM Recent Developments/Updates
Table 148. IBM Competitive Strengths & Weaknesses
Table 149. Intel Basic Information, Area Served and Competitors
Table 150. Intel Major Business
Table 151. Intel Artificial Intelligence in Epidemiology Product and Services
Table 152. Intel Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 153. Intel Recent Developments/Updates
Table 154. Intel Competitive Strengths & Weaknesses
Table 155. InterSystems Basic Information, Area Served and Competitors
Table 156. InterSystems Major Business
Table 157. InterSystems Artificial Intelligence in Epidemiology Product and Services
Table 158. InterSystems Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 159. InterSystems Recent Developments/Updates
Table 160. InterSystems Competitive Strengths & Weaknesses
Table 161. Kareo Basic Information, Area Served and Competitors
Table 162. Kareo Major Business
Table 163. Kareo Artificial Intelligence in Epidemiology Product and Services
Table 164. Kareo Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 165. Kareo Recent Developments/Updates
Table 166. Kareo Competitive Strengths & Weaknesses
Table 167. Medhost Basic Information, Area Served and Competitors
Table 168. Medhost Major Business
Table 169. Medhost Artificial Intelligence in Epidemiology Product and Services
Table 170. Medhost Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 171. Medhost Recent Developments/Updates
Table 172. Medhost Competitive Strengths & Weaknesses
Table 173. Meditech Basic Information, Area Served and Competitors
Table 174. Meditech Major Business
Table 175. Meditech Artificial Intelligence in Epidemiology Product and Services
Table 176. Meditech Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 177. Meditech Recent Developments/Updates
Table 178. Meditech Competitive Strengths & Weaknesses
Table 179. Medtronic Basic Information, Area Served and Competitors
Table 180. Medtronic Major Business
Table 181. Medtronic Artificial Intelligence in Epidemiology Product and Services
Table 182. Medtronic Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 183. Medtronic Recent Developments/Updates
Table 184. Medtronic Competitive Strengths & Weaknesses
Table 185. Micron Technology Basic Information, Area Served and Competitors
Table 186. Micron Technology Major Business
Table 187. Micron Technology Artificial Intelligence in Epidemiology Product and Services
Table 188. Micron Technology Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 189. Micron Technology Recent Developments/Updates
Table 190. Micron Technology Competitive Strengths & Weaknesses
Table 191. Microsoft Basic Information, Area Served and Competitors
Table 192. Microsoft Major Business
Table 193. Microsoft Artificial Intelligence in Epidemiology Product and Services
Table 194. Microsoft Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 195. Microsoft Recent Developments/Updates
Table 196. Microsoft Competitive Strengths & Weaknesses
Table 197. NextGen Healthcare Basic Information, Area Served and Competitors
Table 198. NextGen Healthcare Major Business
Table 199. NextGen Healthcare Artificial Intelligence in Epidemiology Product and Services
Table 200. NextGen Healthcare Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 201. NextGen Healthcare Recent Developments/Updates
Table 202. NextGen Healthcare Competitive Strengths & Weaknesses
Table 203. Nvidia Basic Information, Area Served and Competitors
Table 204. NvidiaMajor Business
Table 205. Nvidia Artificial Intelligence in Epidemiology Product and Services
Table 206. Nvidia Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 207. Nvidia Recent Developments/Updates
Table 208. Optum Inc. Basic Information, Area Served and Competitors
Table 209. Optum Inc. Major Business
Table 210. Optum Inc. Artificial Intelligence in Epidemiology Product and Services
Table 211. Optum Inc. Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 212. Global Key Players of Artificial Intelligence in Epidemiology Upstream (Raw Materials)
Table 213. Artificial Intelligence in Epidemiology Typical Customers
List of Figure
Figure 1. Artificial Intelligence in Epidemiology Picture
Figure 2. World Artificial Intelligence in Epidemiology Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Artificial Intelligence in Epidemiology Total Market Size (2019-2030) & (USD Million)
Figure 4. World Artificial Intelligence in Epidemiology Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Artificial Intelligence in Epidemiology Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Artificial Intelligence in Epidemiology Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Artificial Intelligence in Epidemiology Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Artificial Intelligence in Epidemiology Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Artificial Intelligence in Epidemiology Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Artificial Intelligence in Epidemiology Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Artificial Intelligence in Epidemiology Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Artificial Intelligence in Epidemiology Revenue (2019-2030) & (USD Million)
Figure 13. Artificial Intelligence in Epidemiology Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Artificial Intelligence in Epidemiology Consumption Value (2019-2030) & (USD Million)
Figure 16. World Artificial Intelligence in Epidemiology Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Artificial Intelligence in Epidemiology Consumption Value (2019-2030) & (USD Million)
Figure 18. China Artificial Intelligence in Epidemiology Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Artificial Intelligence in Epidemiology Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Artificial Intelligence in Epidemiology Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Artificial Intelligence in Epidemiology Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Artificial Intelligence in Epidemiology Consumption Value (2019-2030) & (USD Million)
Figure 23. India Artificial Intelligence in Epidemiology Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Artificial Intelligence in Epidemiology by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Artificial Intelligence in Epidemiology Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Artificial Intelligence in Epidemiology Markets in 2023
Figure 27. United States VS China: Artificial Intelligence in Epidemiology Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Artificial Intelligence in Epidemiology Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Artificial Intelligence in Epidemiology Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Artificial Intelligence in Epidemiology Market Size Market Share by Type in 2023
Figure 31. Hardware Technology
Figure 32. Software Technology
Figure 33. World Artificial Intelligence in Epidemiology Market Size Market Share by Type (2019-2030)
Figure 34. World Artificial Intelligence in Epidemiology Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 35. World Artificial Intelligence in Epidemiology Market Size Market Share by Application in 2023
Figure 36. Disease and Syndromic Surveillance
Figure 37. Infection Prediction and Forecasting
Figure 38. Immunization Information Systems
Figure 39. Public Sentiment Analysis
Figure 40. Environmental Impact Analysis
Figure 41. Drug Discovery, Safety, and Risk Analysis
Figure 42. Monitoring Population and Incidence
Figure 43. Knowledge Representation and Mass Notification
Figure 44. Artificial Intelligence in Epidemiology Industrial Chain
Figure 45. Methodology
Figure 46. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Abbott Informatics
AdvancedMD
Agilent Technologies
Allscripts Healthcare
Athenahealth
Autoscribe Informatics
Cerner Corporation
Change Healthcare
Cognizant
CPSI
CureMD Healthcare
eClinicalWorks
e-Mds Inc.
Epic Systems
GE Healthcare
Google
Graphcore
Greenway Health
IBM
Intel
InterSystems
Kareo
Medhost
Meditech
Medtronic
Micron Technology
Microsoft
NextGen Healthcare
Nvidia
Optum Inc.
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Artificial Intelligence in Epidemiology Supply, Demand and Key Producers, 2024-2030

Global Artificial Intelligence in Epidemiology Supply, Demand and Key Producers, 2024-2030

Page: 167

Published Date: 03 Mar 2024

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Artificial Intelligence in Epidemiology market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

China and the United States are two leaders in AI industry. On the AI 100 list (2022) released by CB Insights, the number of companies in the United States ranks first, with more than 70 companies, followed by the United Kingdom, with 8 companies on the list. China and Canada both holds 5 companies on the list. According to data from the China Academy of Information and Communications Technology, the scale of China's core artificial intelligence industry reached ¥508 billion in 2022, a year-on-year increase of 18%. From 2013 to November 2022, the cumulative number of patent applications for artificial intelligence inventions in the world reached 729,000, and the cumulative number of applications in China reached 389,000, accounting for 53.4%. However, the Global Artificial Intelligence Innovation Index Report 2021 released by the China Institute of Scientific and Technological Information shows that the overall strength of the United States is still far ahead. The number of artificial intelligence companies in the United States is about 4,670, while China has only 880. China's data center is less than 1/120 of that of the United States.

This report studies the global Artificial Intelligence in Epidemiology demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Artificial Intelligence in Epidemiology, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Artificial Intelligence in Epidemiology that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Artificial Intelligence in Epidemiology total market, 2019-2030, (USD Million)
Global Artificial Intelligence in Epidemiology total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Artificial Intelligence in Epidemiology total market, key domestic companies and share, (USD Million)
Global Artificial Intelligence in Epidemiology revenue by player and market share 2019-2024, (USD Million)
Global Artificial Intelligence in Epidemiology total market by Type, CAGR, 2019-2030, (USD Million)
Global Artificial Intelligence in Epidemiology total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Artificial Intelligence in Epidemiology market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Informatics, AdvancedMD, Agilent Technologies, Allscripts Healthcare, Athenahealth, Autoscribe Informatics, Cerner Corporation, Change Healthcare and Cognizant, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Artificial Intelligence in Epidemiology market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Artificial Intelligence in Epidemiology Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Artificial Intelligence in Epidemiology Market, Segmentation by Type
Hardware Technology
Software Technology

Global Artificial Intelligence in Epidemiology Market, Segmentation by Application
Disease and Syndromic Surveillance
Infection Prediction and Forecasting
Immunization Information Systems
Public Sentiment Analysis
Environmental Impact Analysis
Drug Discovery, Safety, and Risk Analysis
Monitoring Population and Incidence
Knowledge Representation and Mass Notification

Companies Profiled:
Abbott Informatics
AdvancedMD
Agilent Technologies
Allscripts Healthcare
Athenahealth
Autoscribe Informatics
Cerner Corporation
Change Healthcare
Cognizant
CPSI
CureMD Healthcare
eClinicalWorks
e-Mds Inc.
Epic Systems
GE Healthcare
Google
Graphcore
Greenway Health
IBM
Intel
InterSystems
Kareo
Medhost
Meditech
Medtronic
Micron Technology
Microsoft
NextGen Healthcare
Nvidia
Optum Inc.

Key Questions Answered
1. How big is the global Artificial Intelligence in Epidemiology market?
2. What is the demand of the global Artificial Intelligence in Epidemiology market?
3. What is the year over year growth of the global Artificial Intelligence in Epidemiology market?
4. What is the total value of the global Artificial Intelligence in Epidemiology market?
5. Who are the major players in the global Artificial Intelligence in Epidemiology market?
btl

Table of Contents

1 Supply Summary
1.1 Artificial Intelligence in Epidemiology Introduction
1.2 World Artificial Intelligence in Epidemiology Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Artificial Intelligence in Epidemiology Total Market by Region (by Headquarter Location)
1.3.1 World Artificial Intelligence in Epidemiology Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Artificial Intelligence in Epidemiology Market Size (2019-2030)
1.3.3 China Artificial Intelligence in Epidemiology Market Size (2019-2030)
1.3.4 Europe Artificial Intelligence in Epidemiology Market Size (2019-2030)
1.3.5 Japan Artificial Intelligence in Epidemiology Market Size (2019-2030)
1.3.6 South Korea Artificial Intelligence in Epidemiology Market Size (2019-2030)
1.3.7 ASEAN Artificial Intelligence in Epidemiology Market Size (2019-2030)
1.3.8 India Artificial Intelligence in Epidemiology Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Artificial Intelligence in Epidemiology Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Artificial Intelligence in Epidemiology Major Market Trends

2 Demand Summary
2.1 World Artificial Intelligence in Epidemiology Consumption Value (2019-2030)
2.2 World Artificial Intelligence in Epidemiology Consumption Value by Region
2.2.1 World Artificial Intelligence in Epidemiology Consumption Value by Region (2019-2024)
2.2.2 World Artificial Intelligence in Epidemiology Consumption Value Forecast by Region (2025-2030)
2.3 United States Artificial Intelligence in Epidemiology Consumption Value (2019-2030)
2.4 China Artificial Intelligence in Epidemiology Consumption Value (2019-2030)
2.5 Europe Artificial Intelligence in Epidemiology Consumption Value (2019-2030)
2.6 Japan Artificial Intelligence in Epidemiology Consumption Value (2019-2030)
2.7 South Korea Artificial Intelligence in Epidemiology Consumption Value (2019-2030)
2.8 ASEAN Artificial Intelligence in Epidemiology Consumption Value (2019-2030)
2.9 India Artificial Intelligence in Epidemiology Consumption Value (2019-2030)

3 World Artificial Intelligence in Epidemiology Companies Competitive Analysis
3.1 World Artificial Intelligence in Epidemiology Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Artificial Intelligence in Epidemiology Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Artificial Intelligence in Epidemiology in 2023
3.2.3 Global Concentration Ratios (CR8) for Artificial Intelligence in Epidemiology in 2023
3.3 Artificial Intelligence in Epidemiology Company Evaluation Quadrant
3.4 Artificial Intelligence in Epidemiology Market: Overall Company Footprint Analysis
3.4.1 Artificial Intelligence in Epidemiology Market: Region Footprint
3.4.2 Artificial Intelligence in Epidemiology Market: Company Product Type Footprint
3.4.3 Artificial Intelligence in Epidemiology Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: Artificial Intelligence in Epidemiology Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Artificial Intelligence in Epidemiology Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Artificial Intelligence in Epidemiology Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Artificial Intelligence in Epidemiology Consumption Value Comparison
4.2.1 United States VS China: Artificial Intelligence in Epidemiology Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Artificial Intelligence in Epidemiology Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Artificial Intelligence in Epidemiology Companies and Market Share, 2019-2024
4.3.1 United States Based Artificial Intelligence in Epidemiology Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Artificial Intelligence in Epidemiology Revenue, (2019-2024)
4.4 China Based Companies Artificial Intelligence in Epidemiology Revenue and Market Share, 2019-2024
4.4.1 China Based Artificial Intelligence in Epidemiology Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Artificial Intelligence in Epidemiology Revenue, (2019-2024)
4.5 Rest of World Based Artificial Intelligence in Epidemiology Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Artificial Intelligence in Epidemiology Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Artificial Intelligence in Epidemiology Revenue, (2019-2024)

5 Market Analysis by Type
5.1 World Artificial Intelligence in Epidemiology Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Hardware Technology
5.2.2 Software Technology
5.3 Market Segment by Type
5.3.1 World Artificial Intelligence in Epidemiology Market Size by Type (2019-2024)
5.3.2 World Artificial Intelligence in Epidemiology Market Size by Type (2025-2030)
5.3.3 World Artificial Intelligence in Epidemiology Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
6.1 World Artificial Intelligence in Epidemiology Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Disease and Syndromic Surveillance
6.2.2 Infection Prediction and Forecasting
6.2.3 Immunization Information Systems
6.2.4 Public Sentiment Analysis
6.2.5 Public Sentiment Analysis
6.2.6 Drug Discovery, Safety, and Risk Analysis
6.2.7 Monitoring Population and Incidence
6.2.8 Knowledge Representation and Mass Notification
6.3 Market Segment by Application
6.3.1 World Artificial Intelligence in Epidemiology Market Size by Application (2019-2024)
6.3.2 World Artificial Intelligence in Epidemiology Market Size by Application (2025-2030)
6.3.3 World Artificial Intelligence in Epidemiology Market Size by Application (2019-2030)

7 Company Profiles
7.1 Abbott Informatics
7.1.1 Abbott Informatics Details
7.1.2 Abbott Informatics Major Business
7.1.3 Abbott Informatics Artificial Intelligence in Epidemiology Product and Services
7.1.4 Abbott Informatics Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Abbott Informatics Recent Developments/Updates
7.1.6 Abbott Informatics Competitive Strengths & Weaknesses
7.2 AdvancedMD
7.2.1 AdvancedMD Details
7.2.2 AdvancedMD Major Business
7.2.3 AdvancedMD Artificial Intelligence in Epidemiology Product and Services
7.2.4 AdvancedMD Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 AdvancedMD Recent Developments/Updates
7.2.6 AdvancedMD Competitive Strengths & Weaknesses
7.3 Agilent Technologies
7.3.1 Agilent Technologies Details
7.3.2 Agilent Technologies Major Business
7.3.3 Agilent Technologies Artificial Intelligence in Epidemiology Product and Services
7.3.4 Agilent Technologies Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Agilent Technologies Recent Developments/Updates
7.3.6 Agilent Technologies Competitive Strengths & Weaknesses
7.4 Allscripts Healthcare
7.4.1 Allscripts Healthcare Details
7.4.2 Allscripts Healthcare Major Business
7.4.3 Allscripts Healthcare Artificial Intelligence in Epidemiology Product and Services
7.4.4 Allscripts Healthcare Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Allscripts Healthcare Recent Developments/Updates
7.4.6 Allscripts Healthcare Competitive Strengths & Weaknesses
7.5 Athenahealth
7.5.1 Athenahealth Details
7.5.2 Athenahealth Major Business
7.5.3 Athenahealth Artificial Intelligence in Epidemiology Product and Services
7.5.4 Athenahealth Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Athenahealth Recent Developments/Updates
7.5.6 Athenahealth Competitive Strengths & Weaknesses
7.6 Autoscribe Informatics
7.6.1 Autoscribe Informatics Details
7.6.2 Autoscribe Informatics Major Business
7.6.3 Autoscribe Informatics Artificial Intelligence in Epidemiology Product and Services
7.6.4 Autoscribe Informatics Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Autoscribe Informatics Recent Developments/Updates
7.6.6 Autoscribe Informatics Competitive Strengths & Weaknesses
7.7 Cerner Corporation
7.7.1 Cerner Corporation Details
7.7.2 Cerner Corporation Major Business
7.7.3 Cerner Corporation Artificial Intelligence in Epidemiology Product and Services
7.7.4 Cerner Corporation Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Cerner Corporation Recent Developments/Updates
7.7.6 Cerner Corporation Competitive Strengths & Weaknesses
7.8 Change Healthcare
7.8.1 Change Healthcare Details
7.8.2 Change Healthcare Major Business
7.8.3 Change Healthcare Artificial Intelligence in Epidemiology Product and Services
7.8.4 Change Healthcare Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Change Healthcare Recent Developments/Updates
7.8.6 Change Healthcare Competitive Strengths & Weaknesses
7.9 Cognizant
7.9.1 Cognizant Details
7.9.2 Cognizant Major Business
7.9.3 Cognizant Artificial Intelligence in Epidemiology Product and Services
7.9.4 Cognizant Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Cognizant Recent Developments/Updates
7.9.6 Cognizant Competitive Strengths & Weaknesses
7.10 CPSI
7.10.1 CPSI Details
7.10.2 CPSI Major Business
7.10.3 CPSI Artificial Intelligence in Epidemiology Product and Services
7.10.4 CPSI Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 CPSI Recent Developments/Updates
7.10.6 CPSI Competitive Strengths & Weaknesses
7.11 CureMD Healthcare
7.11.1 CureMD Healthcare Details
7.11.2 CureMD Healthcare Major Business
7.11.3 CureMD Healthcare Artificial Intelligence in Epidemiology Product and Services
7.11.4 CureMD Healthcare Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 CureMD Healthcare Recent Developments/Updates
7.11.6 CureMD Healthcare Competitive Strengths & Weaknesses
7.12 eClinicalWorks
7.12.1 eClinicalWorks Details
7.12.2 eClinicalWorks Major Business
7.12.3 eClinicalWorks Artificial Intelligence in Epidemiology Product and Services
7.12.4 eClinicalWorks Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 eClinicalWorks Recent Developments/Updates
7.12.6 eClinicalWorks Competitive Strengths & Weaknesses
7.13 e-Mds Inc.
7.13.1 e-Mds Inc. Details
7.13.2 e-Mds Inc. Major Business
7.13.3 e-Mds Inc. Artificial Intelligence in Epidemiology Product and Services
7.13.4 e-Mds Inc. Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 e-Mds Inc. Recent Developments/Updates
7.13.6 e-Mds Inc. Competitive Strengths & Weaknesses
7.14 Epic Systems
7.14.1 Epic Systems Details
7.14.2 Epic Systems Major Business
7.14.3 Epic Systems Artificial Intelligence in Epidemiology Product and Services
7.14.4 Epic Systems Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.14.5 Epic Systems Recent Developments/Updates
7.14.6 Epic Systems Competitive Strengths & Weaknesses
7.15 GE Healthcare
7.15.1 GE Healthcare Details
7.15.2 GE Healthcare Major Business
7.15.3 GE Healthcare Artificial Intelligence in Epidemiology Product and Services
7.15.4 GE Healthcare Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.15.5 GE Healthcare Recent Developments/Updates
7.15.6 GE Healthcare Competitive Strengths & Weaknesses
7.16 Google
7.16.1 Google Details
7.16.2 Google Major Business
7.16.3 Google Artificial Intelligence in Epidemiology Product and Services
7.16.4 Google Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.16.5 Google Recent Developments/Updates
7.16.6 Google Competitive Strengths & Weaknesses
7.17 Graphcore
7.17.1 Graphcore Details
7.17.2 Graphcore Major Business
7.17.3 Graphcore Artificial Intelligence in Epidemiology Product and Services
7.17.4 Graphcore Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.17.5 Graphcore Recent Developments/Updates
7.17.6 Graphcore Competitive Strengths & Weaknesses
7.18 Greenway Health
7.18.1 Greenway Health Details
7.18.2 Greenway Health Major Business
7.18.3 Greenway Health Artificial Intelligence in Epidemiology Product and Services
7.18.4 Greenway Health Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.18.5 Greenway Health Recent Developments/Updates
7.18.6 Greenway Health Competitive Strengths & Weaknesses
7.19 IBM
7.19.1 IBM Details
7.19.2 IBM Major Business
7.19.3 IBM Artificial Intelligence in Epidemiology Product and Services
7.19.4 IBM Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.19.5 IBM Recent Developments/Updates
7.19.6 IBM Competitive Strengths & Weaknesses
7.20 Intel
7.20.1 Intel Details
7.20.2 Intel Major Business
7.20.3 Intel Artificial Intelligence in Epidemiology Product and Services
7.20.4 Intel Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.20.5 Intel Recent Developments/Updates
7.20.6 Intel Competitive Strengths & Weaknesses
7.21 InterSystems
7.21.1 InterSystems Details
7.21.2 InterSystems Major Business
7.21.3 InterSystems Artificial Intelligence in Epidemiology Product and Services
7.21.4 InterSystems Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.21.5 InterSystems Recent Developments/Updates
7.21.6 InterSystems Competitive Strengths & Weaknesses
7.22 Kareo
7.22.1 Kareo Details
7.22.2 Kareo Major Business
7.22.3 Kareo Artificial Intelligence in Epidemiology Product and Services
7.22.4 Kareo Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.22.5 Kareo Recent Developments/Updates
7.22.6 Kareo Competitive Strengths & Weaknesses
7.23 Medhost
7.23.1 Medhost Details
7.23.2 Medhost Major Business
7.23.3 Medhost Artificial Intelligence in Epidemiology Product and Services
7.23.4 Medhost Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.23.5 Medhost Recent Developments/Updates
7.23.6 Medhost Competitive Strengths & Weaknesses
7.24 Meditech
7.24.1 Meditech Details
7.24.2 Meditech Major Business
7.24.3 Meditech Artificial Intelligence in Epidemiology Product and Services
7.24.4 Meditech Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.24.5 Meditech Recent Developments/Updates
7.24.6 Meditech Competitive Strengths & Weaknesses
7.25 Medtronic
7.25.1 Medtronic Details
7.25.2 Medtronic Major Business
7.25.3 Medtronic Artificial Intelligence in Epidemiology Product and Services
7.25.4 Medtronic Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.25.5 Medtronic Recent Developments/Updates
7.25.6 Medtronic Competitive Strengths & Weaknesses
7.26 Micron Technology
7.26.1 Micron Technology Details
7.26.2 Micron Technology Major Business
7.26.3 Micron Technology Artificial Intelligence in Epidemiology Product and Services
7.26.4 Micron Technology Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.26.5 Micron Technology Recent Developments/Updates
7.26.6 Micron Technology Competitive Strengths & Weaknesses
7.27 Microsoft
7.27.1 Microsoft Details
7.27.2 Microsoft Major Business
7.27.3 Microsoft Artificial Intelligence in Epidemiology Product and Services
7.27.4 Microsoft Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.27.5 Microsoft Recent Developments/Updates
7.27.6 Microsoft Competitive Strengths & Weaknesses
7.28 NextGen Healthcare
7.28.1 NextGen Healthcare Details
7.28.2 NextGen Healthcare Major Business
7.28.3 NextGen Healthcare Artificial Intelligence in Epidemiology Product and Services
7.28.4 NextGen Healthcare Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.28.5 NextGen Healthcare Recent Developments/Updates
7.28.6 NextGen Healthcare Competitive Strengths & Weaknesses
7.29 Nvidia
7.29.1 Nvidia Details
7.29.2 Nvidia Major Business
7.29.3 Nvidia Artificial Intelligence in Epidemiology Product and Services
7.29.4 Nvidia Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.29.5 Nvidia Recent Developments/Updates
7.29.6 Nvidia Competitive Strengths & Weaknesses
7.30 Optum Inc.
7.30.1 Optum Inc. Details
7.30.2 Optum Inc. Major Business
7.30.3 Optum Inc. Artificial Intelligence in Epidemiology Product and Services
7.30.4 Optum Inc. Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024)
7.30.5 Optum Inc. Recent Developments/Updates
7.30.6 Optum Inc. Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Artificial Intelligence in Epidemiology Industry Chain
8.2 Artificial Intelligence in Epidemiology Upstream Analysis
8.3 Artificial Intelligence in Epidemiology Midstream Analysis
8.4 Artificial Intelligence in Epidemiology Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Artificial Intelligence in Epidemiology Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Artificial Intelligence in Epidemiology Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Artificial Intelligence in Epidemiology Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Artificial Intelligence in Epidemiology Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Artificial Intelligence in Epidemiology Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Artificial Intelligence in Epidemiology Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Artificial Intelligence in Epidemiology Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Artificial Intelligence in Epidemiology Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Artificial Intelligence in Epidemiology Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Artificial Intelligence in Epidemiology Players in 2023
Table 12. World Artificial Intelligence in Epidemiology Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Artificial Intelligence in Epidemiology Company Evaluation Quadrant
Table 14. Head Office of Key Artificial Intelligence in Epidemiology Player
Table 15. Artificial Intelligence in Epidemiology Market: Company Product Type Footprint
Table 16. Artificial Intelligence in Epidemiology Market: Company Product Application Footprint
Table 17. Artificial Intelligence in Epidemiology Mergers & Acquisitions Activity
Table 18. United States VS China Artificial Intelligence in Epidemiology Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Artificial Intelligence in Epidemiology Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Artificial Intelligence in Epidemiology Companies, Headquarters (States, Country)
Table 21. United States Based Companies Artificial Intelligence in Epidemiology Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Artificial Intelligence in Epidemiology Revenue Market Share (2019-2024)
Table 23. China Based Artificial Intelligence in Epidemiology Companies, Headquarters (Province, Country)
Table 24. China Based Companies Artificial Intelligence in Epidemiology Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Artificial Intelligence in Epidemiology Revenue Market Share (2019-2024)
Table 26. Rest of World Based Artificial Intelligence in Epidemiology Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Artificial Intelligence in Epidemiology Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Artificial Intelligence in Epidemiology Revenue Market Share (2019-2024)
Table 29. World Artificial Intelligence in Epidemiology Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Artificial Intelligence in Epidemiology Market Size by Type (2019-2024) & (USD Million)
Table 31. World Artificial Intelligence in Epidemiology Market Size by Type (2025-2030) & (USD Million)
Table 32. World Artificial Intelligence in Epidemiology Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Artificial Intelligence in Epidemiology Market Size by Application (2019-2024) & (USD Million)
Table 34. World Artificial Intelligence in Epidemiology Market Size by Application (2025-2030) & (USD Million)
Table 35. Abbott Informatics Basic Information, Area Served and Competitors
Table 36. Abbott Informatics Major Business
Table 37. Abbott Informatics Artificial Intelligence in Epidemiology Product and Services
Table 38. Abbott Informatics Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Abbott Informatics Recent Developments/Updates
Table 40. Abbott Informatics Competitive Strengths & Weaknesses
Table 41. AdvancedMD Basic Information, Area Served and Competitors
Table 42. AdvancedMD Major Business
Table 43. AdvancedMD Artificial Intelligence in Epidemiology Product and Services
Table 44. AdvancedMD Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. AdvancedMD Recent Developments/Updates
Table 46. AdvancedMD Competitive Strengths & Weaknesses
Table 47. Agilent Technologies Basic Information, Area Served and Competitors
Table 48. Agilent Technologies Major Business
Table 49. Agilent Technologies Artificial Intelligence in Epidemiology Product and Services
Table 50. Agilent Technologies Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Agilent Technologies Recent Developments/Updates
Table 52. Agilent Technologies Competitive Strengths & Weaknesses
Table 53. Allscripts Healthcare Basic Information, Area Served and Competitors
Table 54. Allscripts Healthcare Major Business
Table 55. Allscripts Healthcare Artificial Intelligence in Epidemiology Product and Services
Table 56. Allscripts Healthcare Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Allscripts Healthcare Recent Developments/Updates
Table 58. Allscripts Healthcare Competitive Strengths & Weaknesses
Table 59. Athenahealth Basic Information, Area Served and Competitors
Table 60. Athenahealth Major Business
Table 61. Athenahealth Artificial Intelligence in Epidemiology Product and Services
Table 62. Athenahealth Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Athenahealth Recent Developments/Updates
Table 64. Athenahealth Competitive Strengths & Weaknesses
Table 65. Autoscribe Informatics Basic Information, Area Served and Competitors
Table 66. Autoscribe Informatics Major Business
Table 67. Autoscribe Informatics Artificial Intelligence in Epidemiology Product and Services
Table 68. Autoscribe Informatics Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Autoscribe Informatics Recent Developments/Updates
Table 70. Autoscribe Informatics Competitive Strengths & Weaknesses
Table 71. Cerner Corporation Basic Information, Area Served and Competitors
Table 72. Cerner Corporation Major Business
Table 73. Cerner Corporation Artificial Intelligence in Epidemiology Product and Services
Table 74. Cerner Corporation Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Cerner Corporation Recent Developments/Updates
Table 76. Cerner Corporation Competitive Strengths & Weaknesses
Table 77. Change Healthcare Basic Information, Area Served and Competitors
Table 78. Change Healthcare Major Business
Table 79. Change Healthcare Artificial Intelligence in Epidemiology Product and Services
Table 80. Change Healthcare Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Change Healthcare Recent Developments/Updates
Table 82. Change Healthcare Competitive Strengths & Weaknesses
Table 83. Cognizant Basic Information, Area Served and Competitors
Table 84. Cognizant Major Business
Table 85. Cognizant Artificial Intelligence in Epidemiology Product and Services
Table 86. Cognizant Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Cognizant Recent Developments/Updates
Table 88. Cognizant Competitive Strengths & Weaknesses
Table 89. CPSI Basic Information, Area Served and Competitors
Table 90. CPSI Major Business
Table 91. CPSI Artificial Intelligence in Epidemiology Product and Services
Table 92. CPSI Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. CPSI Recent Developments/Updates
Table 94. CPSI Competitive Strengths & Weaknesses
Table 95. CureMD Healthcare Basic Information, Area Served and Competitors
Table 96. CureMD Healthcare Major Business
Table 97. CureMD Healthcare Artificial Intelligence in Epidemiology Product and Services
Table 98. CureMD Healthcare Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. CureMD Healthcare Recent Developments/Updates
Table 100. CureMD Healthcare Competitive Strengths & Weaknesses
Table 101. eClinicalWorks Basic Information, Area Served and Competitors
Table 102. eClinicalWorks Major Business
Table 103. eClinicalWorks Artificial Intelligence in Epidemiology Product and Services
Table 104. eClinicalWorks Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. eClinicalWorks Recent Developments/Updates
Table 106. eClinicalWorks Competitive Strengths & Weaknesses
Table 107. e-Mds Inc. Basic Information, Area Served and Competitors
Table 108. e-Mds Inc. Major Business
Table 109. e-Mds Inc. Artificial Intelligence in Epidemiology Product and Services
Table 110. e-Mds Inc. Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. e-Mds Inc. Recent Developments/Updates
Table 112. e-Mds Inc. Competitive Strengths & Weaknesses
Table 113. Epic Systems Basic Information, Area Served and Competitors
Table 114. Epic Systems Major Business
Table 115. Epic Systems Artificial Intelligence in Epidemiology Product and Services
Table 116. Epic Systems Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 117. Epic Systems Recent Developments/Updates
Table 118. Epic Systems Competitive Strengths & Weaknesses
Table 119. GE Healthcare Basic Information, Area Served and Competitors
Table 120. GE Healthcare Major Business
Table 121. GE Healthcare Artificial Intelligence in Epidemiology Product and Services
Table 122. GE Healthcare Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 123. GE Healthcare Recent Developments/Updates
Table 124. GE Healthcare Competitive Strengths & Weaknesses
Table 125. Google Basic Information, Area Served and Competitors
Table 126. Google Major Business
Table 127. Google Artificial Intelligence in Epidemiology Product and Services
Table 128. Google Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 129. Google Recent Developments/Updates
Table 130. Google Competitive Strengths & Weaknesses
Table 131. Graphcore Basic Information, Area Served and Competitors
Table 132. Graphcore Major Business
Table 133. Graphcore Artificial Intelligence in Epidemiology Product and Services
Table 134. Graphcore Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 135. Graphcore Recent Developments/Updates
Table 136. Graphcore Competitive Strengths & Weaknesses
Table 137. Greenway Health Basic Information, Area Served and Competitors
Table 138. Greenway Health Major Business
Table 139. Greenway Health Artificial Intelligence in Epidemiology Product and Services
Table 140. Greenway Health Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 141. Greenway Health Recent Developments/Updates
Table 142. Greenway Health Competitive Strengths & Weaknesses
Table 143. IBM Basic Information, Area Served and Competitors
Table 144. IBM Major Business
Table 145. IBM Artificial Intelligence in Epidemiology Product and Services
Table 146. IBM Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 147. IBM Recent Developments/Updates
Table 148. IBM Competitive Strengths & Weaknesses
Table 149. Intel Basic Information, Area Served and Competitors
Table 150. Intel Major Business
Table 151. Intel Artificial Intelligence in Epidemiology Product and Services
Table 152. Intel Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 153. Intel Recent Developments/Updates
Table 154. Intel Competitive Strengths & Weaknesses
Table 155. InterSystems Basic Information, Area Served and Competitors
Table 156. InterSystems Major Business
Table 157. InterSystems Artificial Intelligence in Epidemiology Product and Services
Table 158. InterSystems Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 159. InterSystems Recent Developments/Updates
Table 160. InterSystems Competitive Strengths & Weaknesses
Table 161. Kareo Basic Information, Area Served and Competitors
Table 162. Kareo Major Business
Table 163. Kareo Artificial Intelligence in Epidemiology Product and Services
Table 164. Kareo Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 165. Kareo Recent Developments/Updates
Table 166. Kareo Competitive Strengths & Weaknesses
Table 167. Medhost Basic Information, Area Served and Competitors
Table 168. Medhost Major Business
Table 169. Medhost Artificial Intelligence in Epidemiology Product and Services
Table 170. Medhost Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 171. Medhost Recent Developments/Updates
Table 172. Medhost Competitive Strengths & Weaknesses
Table 173. Meditech Basic Information, Area Served and Competitors
Table 174. Meditech Major Business
Table 175. Meditech Artificial Intelligence in Epidemiology Product and Services
Table 176. Meditech Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 177. Meditech Recent Developments/Updates
Table 178. Meditech Competitive Strengths & Weaknesses
Table 179. Medtronic Basic Information, Area Served and Competitors
Table 180. Medtronic Major Business
Table 181. Medtronic Artificial Intelligence in Epidemiology Product and Services
Table 182. Medtronic Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 183. Medtronic Recent Developments/Updates
Table 184. Medtronic Competitive Strengths & Weaknesses
Table 185. Micron Technology Basic Information, Area Served and Competitors
Table 186. Micron Technology Major Business
Table 187. Micron Technology Artificial Intelligence in Epidemiology Product and Services
Table 188. Micron Technology Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 189. Micron Technology Recent Developments/Updates
Table 190. Micron Technology Competitive Strengths & Weaknesses
Table 191. Microsoft Basic Information, Area Served and Competitors
Table 192. Microsoft Major Business
Table 193. Microsoft Artificial Intelligence in Epidemiology Product and Services
Table 194. Microsoft Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 195. Microsoft Recent Developments/Updates
Table 196. Microsoft Competitive Strengths & Weaknesses
Table 197. NextGen Healthcare Basic Information, Area Served and Competitors
Table 198. NextGen Healthcare Major Business
Table 199. NextGen Healthcare Artificial Intelligence in Epidemiology Product and Services
Table 200. NextGen Healthcare Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 201. NextGen Healthcare Recent Developments/Updates
Table 202. NextGen Healthcare Competitive Strengths & Weaknesses
Table 203. Nvidia Basic Information, Area Served and Competitors
Table 204. NvidiaMajor Business
Table 205. Nvidia Artificial Intelligence in Epidemiology Product and Services
Table 206. Nvidia Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 207. Nvidia Recent Developments/Updates
Table 208. Optum Inc. Basic Information, Area Served and Competitors
Table 209. Optum Inc. Major Business
Table 210. Optum Inc. Artificial Intelligence in Epidemiology Product and Services
Table 211. Optum Inc. Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 212. Global Key Players of Artificial Intelligence in Epidemiology Upstream (Raw Materials)
Table 213. Artificial Intelligence in Epidemiology Typical Customers
List of Figure
Figure 1. Artificial Intelligence in Epidemiology Picture
Figure 2. World Artificial Intelligence in Epidemiology Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Artificial Intelligence in Epidemiology Total Market Size (2019-2030) & (USD Million)
Figure 4. World Artificial Intelligence in Epidemiology Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Artificial Intelligence in Epidemiology Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Artificial Intelligence in Epidemiology Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Artificial Intelligence in Epidemiology Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Artificial Intelligence in Epidemiology Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Artificial Intelligence in Epidemiology Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Artificial Intelligence in Epidemiology Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Artificial Intelligence in Epidemiology Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Artificial Intelligence in Epidemiology Revenue (2019-2030) & (USD Million)
Figure 13. Artificial Intelligence in Epidemiology Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Artificial Intelligence in Epidemiology Consumption Value (2019-2030) & (USD Million)
Figure 16. World Artificial Intelligence in Epidemiology Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Artificial Intelligence in Epidemiology Consumption Value (2019-2030) & (USD Million)
Figure 18. China Artificial Intelligence in Epidemiology Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Artificial Intelligence in Epidemiology Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Artificial Intelligence in Epidemiology Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Artificial Intelligence in Epidemiology Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Artificial Intelligence in Epidemiology Consumption Value (2019-2030) & (USD Million)
Figure 23. India Artificial Intelligence in Epidemiology Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Artificial Intelligence in Epidemiology by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Artificial Intelligence in Epidemiology Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Artificial Intelligence in Epidemiology Markets in 2023
Figure 27. United States VS China: Artificial Intelligence in Epidemiology Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Artificial Intelligence in Epidemiology Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Artificial Intelligence in Epidemiology Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Artificial Intelligence in Epidemiology Market Size Market Share by Type in 2023
Figure 31. Hardware Technology
Figure 32. Software Technology
Figure 33. World Artificial Intelligence in Epidemiology Market Size Market Share by Type (2019-2030)
Figure 34. World Artificial Intelligence in Epidemiology Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 35. World Artificial Intelligence in Epidemiology Market Size Market Share by Application in 2023
Figure 36. Disease and Syndromic Surveillance
Figure 37. Infection Prediction and Forecasting
Figure 38. Immunization Information Systems
Figure 39. Public Sentiment Analysis
Figure 40. Environmental Impact Analysis
Figure 41. Drug Discovery, Safety, and Risk Analysis
Figure 42. Monitoring Population and Incidence
Figure 43. Knowledge Representation and Mass Notification
Figure 44. Artificial Intelligence in Epidemiology Industrial Chain
Figure 45. Methodology
Figure 46. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Abbott Informatics
AdvancedMD
Agilent Technologies
Allscripts Healthcare
Athenahealth
Autoscribe Informatics
Cerner Corporation
Change Healthcare
Cognizant
CPSI
CureMD Healthcare
eClinicalWorks
e-Mds Inc.
Epic Systems
GE Healthcare
Google
Graphcore
Greenway Health
IBM
Intel
InterSystems
Kareo
Medhost
Meditech
Medtronic
Micron Technology
Microsoft
NextGen Healthcare
Nvidia
Optum Inc.
jiaGou

Add To Cart

gouMai

Buy Now